- Home
- ADPT vs HMN Comparison
ADPT vs HMN Comparison
Compare ADPT & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- HMN
- Stock Information
- Founded
- ADPT 2009
- HMN 1945
- Country
- ADPT United States
- HMN United States
- Employees
- ADPT N/A
- HMN N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- HMN Property-Casualty Insurers
- Sector
- ADPT Health Care
- HMN Finance
- Exchange
- ADPT Nasdaq
- HMN Nasdaq
- Market Cap
- ADPT 1.8B
- HMN 1.7B
- IPO Year
- ADPT 2019
- HMN 1991
- Fundamental
- Price
- ADPT $10.75
- HMN $40.64
- Analyst Decision
- ADPT Strong Buy
- HMN Buy
- Analyst Count
- ADPT 7
- HMN 4
- Target Price
- ADPT $10.57
- HMN $46.33
- AVG Volume (30 Days)
- ADPT 2.1M
- HMN 272.3K
- Earning Date
- ADPT 08-05-2025
- HMN 08-06-2025
- Dividend Yield
- ADPT N/A
- HMN 3.36%
- EPS Growth
- ADPT N/A
- HMN 75.77
- EPS
- ADPT N/A
- HMN 2.76
- Revenue
- ADPT $189,527,000.00
- HMN $1,625,600,000.00
- Revenue This Year
- ADPT $24.39
- HMN $7.70
- Revenue Next Year
- ADPT $20.44
- HMN $5.70
- P/E Ratio
- ADPT N/A
- HMN $15.08
- Revenue Growth
- ADPT 8.61
- HMN 6.67
- 52 Week Low
- ADPT $3.85
- HMN $31.95
- 52 Week High
- ADPT $12.43
- HMN $44.44
- Technical
- Relative Strength Index (RSI)
- ADPT 48.31
- HMN 41.31
- Support Level
- ADPT $10.22
- HMN $40.82
- Resistance Level
- ADPT $11.18
- HMN $41.82
- Average True Range (ATR)
- ADPT 0.51
- HMN 0.70
- MACD
- ADPT -0.15
- HMN 0.02
- Stochastic Oscillator
- ADPT 24.82
- HMN 30.20
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About HMN Horace Mann Educators Corporation
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.